The prognostic significance of margin width for extremity and trunk sarcoma

被引:149
作者
McKee, MD
Liu, DF
Brooks, JJ
Gibbs, JF
Driscoll, DL
Kraybill, WG
机构
[1] Roswell Pk Canc Inst, Div Surg Oncol, Buffalo, NY 14263 USA
[2] SUNY Buffalo, Buffalo, NY 14260 USA
[3] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA
关键词
soft tissue sarcoma; extremity sarcoma; surgical margin; local recurrence; distant metastases;
D O I
10.1002/jso.20009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: To evaluate the significance of resection margin for soft tissue sarcoma (STS), we determined local recurrence-free interval (LRFI), distant metastases-free interval (DMFI), and overall survival (OS) for primary extremity and truncal STS with clear margins (greater than or equal to10 mm), close margins (1-9 mm), and positive margins (0 mm). Methods: Patients were evaluated via review of charts and tumor specimens. Results: Among 111 patients, tumors were predominantly high grade (86%), greater than or equal to5 cm (76%), and deep (81%). A minority of patients received adjuvant radiation (38%) and/or adjuvant chemotherapy (34%). Margin width was greater than or equal to10 mm (48%), 1-9 mm (40%), or 0 mm (12%). Margins greater than or equal to10 mm. were less common for large (P = 0.009) or deep (P = 0.02) tumors. By multivariate analysis, independent factors for LRFI were tumor size (P = 0.04) and margin width (P = 0.03). Independent factors related to DMFI were tumor grade (P = 0.002), size (P = 0.007), and patient age (P = 0.02). Independent factors relating to OS were tumor grade (P = 0.001), size (P = 0.004), and depth (P = 0.03). Conclusions: Margins greater than or equal to 10 mm independently predicted longer LRFI and are optimal for extremity STS resection. Adjuvant radiotherapy should be considered for all STS resected with margins < 10 mm, and margin width should be considered when reporting and interpreting LR outcomes for these patients. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:68 / 76
页数:9
相关论文
共 29 条
[1]   Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity [J].
Alektiar, KM ;
Leung, D ;
Zelefsky, MJ ;
Healey, JH ;
Brennan, MF .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (01) :48-56
[2]  
[Anonymous], 1997, AJCC CANC STAGING MA
[3]   TREATMENT OF SOFT-TISSUE SARCOMAS BY PREOPERATIVE IRRADIATION AND CONSERVATIVE SURGICAL RESECTION [J].
BARKLEY, HT ;
MARTIN, RG ;
ROMSDAHL, MM ;
LINDBERG, R ;
ZAGARS, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (04) :693-699
[4]  
Brennan M. F., 1997, PRINCIPLES PRACTICE, P1738
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]  
Demetri GD, 1998, ONCOLOGY-NY, V12, P183
[7]   THE EFFECT OF LOCAL RECURRENCE ON SURVIVAL-TIME IN ADULT HIGH-GRADE SOFT-TISSUE SARCOMAS [J].
EMRICH, LJ ;
RUKA, W ;
DRISCOLL, DL ;
KARAKOUSIS, CP .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (02) :105-110
[8]  
ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106
[9]   Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial [J].
Frustaci, S ;
Gherlinzoni, F ;
De Paoli, A ;
Bonetti, M ;
Azzarelli, A ;
Comandone, A ;
Olmi, P ;
Buonadonna, A ;
Pignatti, G ;
Barbieri, E ;
Apice, G ;
Zmerly, H ;
Serraino, D ;
Picci, P .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1238-1247
[10]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36